PCV51 A COST-EFFECTIVENESS ASSESSMENT OF DALTEPARIN AS A PROPHYLACTIC AND THERAPEUTIC AGENT FOR THE MANAGEMENT OF THROMBOEMBOLIC VENOUS DISEASE (VTE) IN MEXICAN ADULT PATIENTS AFTER TOTAL HIP REPLACEMENT
May 1, 2009, 00:00
10.1016/S1098-3015(10)73813-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)73813-4/fulltext
Title :
PCV51 A COST-EFFECTIVENESS ASSESSMENT OF DALTEPARIN AS A PROPHYLACTIC AND THERAPEUTIC AGENT FOR THE MANAGEMENT OF THROMBOEMBOLIC VENOUS DISEASE (VTE) IN MEXICAN ADULT PATIENTS AFTER TOTAL HIP REPLACEMENT
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73813-4&doi=10.1016/S1098-3015(10)73813-4
First page :
Section Title :
Open access? :
No
Section Order :
284